This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

TRAMADOL HYDROCHLORIDE

Read time: 1 mins
Marketing start date: 14 Nov 2024
...
 

Summary of product characteristics


Effective Time

20230927

Version

9

Spl Product Data Elements

TRAMADOL HYDROCHLORIDE TRAMADOL HYDROCHLORIDE TRAMADOL HYDROCHLORIDE TRAMADOL ANHYDROUS LACTOSE HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POLYSORBATE 80 SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO TITANIUM DIOXIDE CELLULOSE, MICROCRYSTALLINE WHITE TO OFF-WHITE ROUND 319

Application Number

ANDA090404

Brand Name

TRAMADOL HYDROCHLORIDE

Generic Name

TRAMADOL HYDROCHLORIDE

Product Ndc

65841-754

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Tramadol Hydrochloride Tablets USP, 50 mg NDC 65841-754-01 in bottle of 100 tablets 100 tablets Rx only Tramadol HCl Tablets

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.